TerrAscend
TSX:TSND
C$ 0,91
+ C$0,03 (3,41%)
0,91 C$
+C$0,03 (3,41%)
End-of-day quote: 04/24/2026

TerrAscend Stock Value

Analysts currently rate TSX:TSND as Buy.
Buy
Buy

TerrAscend Company Info

EPS Growth 5Y
19,73%
Market Cap
C$0,27 B
Long-Term Debt
C$0,28 B
Short Interest
2,30%
Quarterly earnings
05/14/2026
Dividend
C$0,00
Dividend Yield
0,00%
Founded
2017
Industry
Country
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

C$1,62
78.02%
78.02
Last Update: 04/24/2026
Analysts: 2

Highest Price Target C$1,99

Average Price Target C$1,62

Lowest Price Target C$1,25

In the last five quarters, TerrAscend’s Price Target has fallen from C$6,02 to C$2,74 - a -54,49% decrease. Two analysts predict that TerrAscend’s share price will increase in the coming year, reaching C$1,62. This would represent an increase of 78,02%.

Top growth stocks in the health care sector (5Y.)

What does TerrAscend do?

TerrAscend Corp. (TerrAscend) operates as a North American cannabis company. The company has vertically-integrated licensed operations in Pennsylvania, New Jersey, Michigan, Maryland, and California. In addition, the company has retail operations in Ontario, Canada, with a majority-owned dispensary in Toronto, Ontario, Canada. The company operates under one reportable segment, which is the cultivation, production, and sale of cannabis products. The company owns a portfolio of operating busine...
×